Back to search
FDAFDA · Food and drugs·Recall number D-1300-2014

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.

Published May 14, 2014 · Recall initiated: April 1, 2014

Summary

FDA records drug Class II recall D-1300-2014, published May 14, 2014 and initiated April 1, 2014. Recalling firm: Wockhardt Usa Inc.; Status: Terminated; Reported quantity: 109,744 bottles; Lot: Lot #: LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Usa Inc.
Distributor
Nationwide
Lot
Lot #: LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1. recalled?

Yes. FDA published recall D-1300-2014 on May 14, 2014. Reported hazard: Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter